STAT+: A journey to witness China’s biotech boom up close
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.